Oligonucleotide Synthesis Market Analysis and Future Scope
by Vijay K. Web MarketingThe
worldwide oligonucleotide synthesis
market
is growing due to favorable government policies, increasing prevalence of
infectious diseases and cancer, advancements in synthesis technology, and ongoing
research in synthetic biology. Valued at $1.5 billion in 2017, the domain is
predicted to progress with a 10.8% CAGR during the forecast period 2018–2023,
ultimately generating $2.8 billion in revenue by 2023. By definition,
oligonucleotide synthesis is the artificial creation of oligonucleotides, which
are short DNA or RNA fragments.
Over
the years, the number of private and public organizations involved in synthetic
biology research has grown significantly. Woodrow Wilson International Center
for Scholars (Wilson Center), in a 2013 article, reported that the number of
companies carrying out research in the field grew from 230 in 2009 to 503 by
2013. Such activities have paved the way for the development of small
chemotherapeutic molecules and advanced biopharmaceuticals. Further,
developments, including microchip-aided production, are leading to
cost-effective and swift manufacturing of oligonucleotides.
Download report sample at: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample
In addition, several new
products have come in the oligonucleotide synthesis market, such as protecting
amino groups, synthesizers with high throughput, and coupling reagents. Similarly,
the development of the microarray technology is aiding the production of
oligonucleotides for the diagnosis and treatment of diseases. Along with making
the nucleotide assembly method efficient and correcting errors in synthesized
enzymes, such developments are also helping in the steady progress of the
market.
Hence,
it is clear that the increase in research and development in the synthetic
biology field will further the market advance.
Sponsor Ads
Created on Oct 10th 2019 03:16. Viewed 243 times.